Microarray Based Screening of Peptide Nano Probes for HER2 Positive Tumor

Analytical Chemistry

Volumn 87, Issue 16, 2015, Pages 8367-8372

  Wang, Zihua ^a   Wang, Weizhi ^a   Bu, Xiangli ^a   Wei, Zewen ^a   Geng, Lingling ^a   Wu, Yue ^b   Dong, Chengyan ^b   Li, Liqiang ^b   Zhang, Di ^a   Yang, Shu ^a   Wang, Fan ^b   Lausted, Christopher ^c   Hood, Leroy ^c   Hu, Zhiyuan ^a,c,d  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^d BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPROBES; ORGANIC POLYMERS; PEPTIDES; PROBES; TUMORS;

DIAGNOSTIC PROBES; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2); IN-VIVO IMAGING; MICROARRAY-BASED SCREENING; NOVEL PEPTIDES; PEPTIDE SCREENING; TUMOR BIOMARKERS; TUMOR TISSUES;

DIAGNOSIS;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE;

ANIMAL; BREAST NEOPLASMS; CHEMISTRY; CONFOCAL MICROSCOPY; EARLY CANCER DIAGNOSIS; FEMALE; GENETICS; HUMAN; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MOUSE; NANOTECHNOLOGY; PROCEDURES; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; EARLY DETECTION OF CANCER; FEMALE; FLUORESCENT DYES; HUMANS; MICE; MICROARRAY ANALYSIS; MICROSCOPY, CONFOCAL; NANOTECHNOLOGY; RECEPTOR, ERBB-2; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84939826094     PISSN: 00032700     EISSN: 15206882     Source Type: Journal    
DOI: 10.1021/acs.analchem.5b01588     Document Type: Article

References (51)

1. Alford, R.; Ogawa, M.; Choyke, P. L.; Kobayashi, H. Molecular probes for the in vivo imaging of cancer Mol. BioSyst. 2009, 5, 1279-1291 10.1039/b911307j
2. Yuan, L.; Lin, W.; Zheng, K.; He, L.; Huang, W. Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging Chem. Soc. Rev. 2013, 42, 622-661 10.1039/C2CS35313J
3. Scott, A. M.; Wolchok, J. D.; Old, L. J. Antibody therapy of cancer Nat. Rev. Cancer 2012, 12, 278-287 10.1038/nrc3236
4. McGuire, M. J.; Gray, B. P.; Li, S.; Cupka, D.; Byers, L. A.; Wu, L.; Rezaie, S.; Liu, Y. H.; Pattisapu, N.; Issac, J.; Oyama, T.; Diao, L.; Heymach, J. V.; Xie, X. J.; Minna, J. D.; Brown, K. C. Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer Sci. Rep. 2014, 4, 4480 10.1038/srep04480
5. Xiong, N.; Dong, X.-Y.; Zheng, J.; Liu, F.-F.; Sun, Y. Design of LVFFARK and LVFFARK-Functionalized Nanoparticles for Inhibiting Amyloid beta-Protein Fibrillation and Cytotoxicity ACS Appl. Mater. Interfaces 2015, 7, 5650-5662 10.1021/acsami.5b00915
6. Yu, Y.; Li, H.; Zhang, B.; Pan, X.; Zhu, X.; Ding, Y.; Li, G. Peptide Network for Detection of Tissue-Remodeling Enzyme in the Prognosis of Hepatocellular Carcinoma ACS Appl. Mater. Interfaces 2015, 7, 4401-4405 10.1021/am5089378
7. Aina, O. H.; Sroka, T. C.; Chen, M. L.; Lam, K. S. Therapeutic cancer targeting peptides Biopolymers 2002, 66, 184-99 10.1002/bip.10257
8. Kim, Y. H.; Jeon, J.; Hong, S. H.; Rhim, W. K.; Lee, Y. S.; Youn, H.; Chung, J. K.; Lee, M. C.; Lee, D. S.; Kang, K. W. Tumor Targeting and Imaging Using Cyclic RGD-PEGylated Gold Nanoparticle Probes with Directly Conjugated Iodine-125 Small 2011, 7, 2052-2060 10.1002/smll.201100927
9. Jin, S.; Wang, Y.; Zhu, H.; Wang, Y.; Zhao, S.; Zhao, M.; Liu, J.; Wu, J.; Gao, W.; Peng, S. Nanosized Aspirin-Arg-Gly-Asp-Val: Delivery of Aspirin to Thrombus by the Target Carrier Arg-Gly-Asp-Val Tetrapeptide ACS Nano 2013, 7, 7664-7673 10.1021/nn402171v
10. Steinmetz, N. F.; Ablack, A. L.; Hickey, J. L.; Ablack, J.; Manocha, B.; Mymryk, J. S.; Luyt, L. G.; Lewis, J. D. Intravital Imaging of Human Prostate Cancer Using Viral Nanoparticles Targeted to Gastrin-Releasing Peptide Receptors Small 2011, 7, 1664-1672 10.1002/smll.201000435
11. Bartneck, M.; Ritz, T.; Keul, H. A.; Wambach, M.; Bornemann, J.; Gbureck, U.; Ehling, J.; Lammers, T.; Heymann, F.; Gassler, N.; Luedde, T.; Trautwein, C.; Groll, J.; Tacke, F. Peptide-Functionalized Gold Nanorods Increase Liver Injury in Hepatitis ACS Nano 2012, 6, 8767-8777 10.1021/nn302502u
12. Shokeen, M.; Pressly, E. D.; Hagooly, A.; Zheleznyak, A.; Ramos, N.; Fiamengo, A. L.; Welch, M. J.; Hawker, C. J.; Anderson, C. J. Evaluation of Multivalent, Functional Polymeric Nanoparticles for Imaging Applications ACS Nano 2011, 5, 738-747 10.1021/nn102278w
13. Zhang, M. Z.; Yu, Y.; Yu, R. N.; Wan, M.; Zhang, R. Y.; Zhao, Y. D. Tracking the Down-Regulation of Folate Receptor-alpha in Cancer Cells through Target Specific Delivery of Quantum Dots Coupled with Antisense Oligonucleotide and Targeted Peptide Small 2013, 9, 4183-4193 10.1002/smll.201300994
14. Gao, J.; Liang, G.; Zhang, B.; Kuang, Y.; Zhang, X.; Xu, B. FePt@CoS2 yolk-shell nanocrystals as a potent agent to kill HeLa cells J. Am. Chem. Soc. 2007, 129, 1428-1433 10.1021/ja067785e
15. Carney, W.; Leitzel, K.; Ali, S.; Neumann, R.; Lipton, A. HER-2/neu diagnostics in breast cancer Breast Cancer Res. 2007, 9, 207 10.1186/bcr1664
16. Montemurro, F.; Scaltriti, M. Biomarkers of drugs targeting HER-family signalling in cancer J. Pathol. 2014, 232, 219-229 10.1002/path.4269
17. Tai, W.; Mahato, R.; Cheng, K. The role of HER2 in cancer therapy and targeted drug delivery J. Controlled Release 2010, 146, 264-75 10.1016/j.jconrel.2010.04.009
18. Gutierrez, C.; Schiff, R. HER2: Biology, Detection, and Clinical Implications Arch. Pathol. Lab. Med. 2011, 135, 55-62 10.1043/2010-0454-RAR.1
19. Arya, S. K.; Lim, B.; Rahman, A. R. Enrichment, detection and clinical significance of circulating tumor cells Lab Chip 2013, 13, 1995-2027 10.1039/c3lc00009e
20. Bai, L.; Du, Y.; Peng, J.; Liu, Y.; Wang, Y.; Yang, Y.; Wang, C. Peptide-based isolation of circulating tumor cells by magnetic nanoparticles J. Mater. Chem. B 2014, 2, 4080-4088 10.1039/c4tb00456f
21. Cristofanilli, M.; Budd, G.; Ellis, M.; Stopeck, A.; Matera, J.; Miller, M.; Reuben, J.; Doyle, G.; Allard, W.; Terstappen, L.; Hayes, D. Circulating tumor cells, disease progression, and survival in metastatic breast cancer N. Engl. J. Med. 2004, 351, 781-791 10.1056/NEJMoa040766
22. Nielsen, D. L.; Andersson, M.; Kamby, C. HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors Cancer Treat. Rev. 2009, 35, 121-36 10.1016/j.ctrv.2008.09.003
23. Larimer, B. M.; Thomas, W. D.; Smith, G. P.; Deutscher, S. L. Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display Mol. Imaging Biol. 2014, 16, 449-58 10.1007/s11307-014-0724-5
24. Sliwkowski, M. X.; Mellman, I. Antibody therapeutics in cancer Science 2013, 341, 1192-1198 10.1126/science.1241145
25. Budd, G.; Cristofanilli, M.; Ellis, M.; Stopeck, A.; Borden, E.; Miller, M.; Matera, J.; Repollet, M.; Doyle, G.; Terstappen, L.; Hayes, D. Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer Clin. Cancer Res. 2006, 12, 6403-6409 10.1158/1078-0432.CCR-05-1769
26. Cho, C. F.; Behnam Azad, B.; Luyt, L. G.; Lewis, J. D. High-throughput screening of one-bead-one-compound peptide libraries using intact cells ACS Comb. Sci. 2013, 15, 393-400 10.1021/co4000584
27. Cho, C. F.; Amadei, G. A.; Breadner, D.; Luyt, L. G.; Lewis, J. D. Discovery of novel integrin ligands from combinatorial libraries using a multiplex 'beads on a bead' approach Nano Lett. 2012, 12, 5957-5965 10.1021/nl3034043
28. Doran, T. M.; Gao, Y.; Mendes, K.; Dean, S.; Simanski, S.; Kodadek, T. Utility of Redundant Combinatorial Libraries in Distinguishing High and Low Quality Screening Hits ACS Comb. Sci. 2014, 16, 259-270 10.1021/co500030f
29. Lian, W.; Upadhyaya, P.; Rhodes, C. A.; Liu, Y.; Pei, D. Screening Bicyclic Peptide Libraries for Protein-Protein Interaction Inhibitors: Discovery of a Tumor Necrosis Factor-alpha Antagonist J. Am. Chem. Soc. 2013, 135, 11990-11995 10.1021/ja405106u
30. Trinh, T. B.; Xiao, Q.; Pei, D. Profiling the Substrate Specificity of Protein Kinases by On-Bead Screening of Peptide Libraries Biochemistry 2013, 52, 5645-5655 10.1021/bi4008947
31. Gao, Y.; Amar, S.; Pahwa, S.; Fields, G. B.; Kodadek, T. Rapid Lead Discovery Through Iterative Screening of One Bead One Compound Libraries ACS Comb. Sci. 2015, 17, 49-59 10.1021/co500154e
32. Astle, J. M.; Simpson, L. S.; Huang, Y.; Reddy, M. M.; Wilson, R.; Connell, S.; Wilson, J.; Kodadek, T. Seamless Bead to Microarray Screening: Rapid Identification of the Highest Affinity Protein Ligands from Large Combinatorial Libraries Chem. Biol. 2010, 17, 38-45 10.1016/j.chembiol.2009.12.015
33. Choi, Y.; Lee, J.; Kim, K.; Kim, H.; Sommer, P.; Song, R. Fluorogenic assay and live cell imaging of HIV-1 protease activity using acid-stable quantum dot-peptide complex Chem. Commun. 2010, 46, 9146-9148 10.1039/c0cc02702b
34. Burns, A. R.; Kwok, T. C. Y.; Howard, A.; Houston, E.; Johanson, K.; Chan, A.; Cutler, S. R.; McCourt, P.; Roy, P. J. High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans Nat. Prot. 2006, 1, 1906-1914 10.1038/nprot.2006.283
35. Price, A. K.; MacConnell, A. B.; Paegel, B. M. Microfluidic Bead Suspension Hopper Anal. Chem. 2014, 86, 5039-5044 10.1021/ac500693r
36. Wang, W.; Wei, Z.; Wang, Z.; Ma, H.; Bu, X.; Hu, Z. Continuous Flow Microfluidic-MS System for Efficient OBOC Screening RSC Adv. 2014, 4, 61767-61770 10.1039/C4RA12911C
37. Wang, W.; Wei, Z.; Zhang, D.; Ma, H.; Wang, Z.; Bu, X.; Li, M.; Geng, L.; Lausted, C.; Hood, L.; Fang, Q.; Wang, H.; Hu, Z. Rapid Screening of Peptide Probes through In Situ Single-Bead Sequencing Microarray Anal. Chem. 2014, 86, 11854-11859 10.1021/ac503454z
38. Wang, W.; Zhang, D.; Wei, Z.; Wang, Z.; Bu, X.; Yang, S.; Fang, Q.; Hu, Z. Label-free detection microarray for novel peptide ligands screening base on MS-SPRi combination Talanta 2015, 134, 705-711 10.1016/j.talanta.2014.12.012
39. Wang, W.; Li, M.; Wei, Z.; Wang, Z.; Bu, X.; Lai, W.; Yang, S.; Gong, H.; Zheng, H.; Wang, Y.; Liu, Y.; Li, Q.; Fang, Q.; Hu, Z. Bimodal Imprint Chips for Peptide Screening: Integration of High-Throughput Sequencing by MS and Affinity Analyses by Surface Plasmon Resonance Imaging Anal. Chem. 2014, 86, 3703-3707 10.1021/ac500465e
40. Hintersteiner, M.; Kimmerlin, T.; Kalthoff, F.; Stoeckli, M.; Garavel, G.; Seifert, J.-M.; Meisner, N.-C.; Uhl, V.; Buehler, C.; Weidemann, T.; Auer, M. Single Bead Labeling Method for Combining Confocal Fluorescence On-Bead Screening and Solution Validation of Tagged One-Bead One-Compound Libraries Chem. Biol. 2009, 16, 724-735 10.1016/j.chembiol.2009.06.011
41. Pei, D. On-Bead Library Screening Made Easier Chem. Biol. 2010, 17, 3-4 10.1016/j.chembiol.2010.01.003
42. Reitinger, S.; Petriv, O. I.; Mehr, K.; Hansen, C. L.; Withers, S. G. Purification and quantitation of bacteriophage M13 using desalting spin columns and digital PCR J. Virol. Methods 2012, 185, 171-174 10.1016/j.jviromet.2012.06.021
43. Jullian, M.; Hernandez, A.; Maurras, A.; Puget, K.; Amblard, M.; Martinez, J.; Subra, G. N-terminus FITC labeling of peptides on solid support: the truth behind the spacer Tetrahedron Lett. 2009, 50, 260-263 10.1016/j.tetlet.2008.10.141
44. Banappagari, S.; McCall, A.; Fontenot, K.; Vicente, M. G.; Gujar, A.; Satyanarayanajois, S. Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domain Eur. J. Med. Chem. 2013, 65, 60-69 10.1016/j.ejmech.2013.04.038
45. Lemmon, M. A. Ligand-induced ErbB receptor dimerization Exp. Cell Res. 2009, 315, 638-648 10.1016/j.yexcr.2008.10.024
46. Franklin, M. C.; Carey, K. D.; Vajdos, F. F.; Leahy, D. J.; de Vos, A. M.; Sliwkowski, M. X. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex Cancer Cell 2004, 5, 317-328 10.1016/S1535-6108(04)00083-2
47. Bostrom, J.; Yu, S. F.; Kan, D.; Appleton, B. A.; Lee, C. V.; Billeci, K.; Man, W.; Peale, F.; Ross, S.; Wiesmann, C.; Fuh, G. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site Science 2009, 323, 1610-1614 10.1126/science.1165480
48. Garrett, T. P. J.; McKern, N. M.; Lou, M. Z.; Elleman, T. C.; Adams, T. E.; Lovrecz, G. O.; Zhu, H. J.; Walker, F.; Frenkel, M. J.; Hoyne, P. A.; Jorissen, R. N.; Nice, E. C.; Burgess, A. W.; Ward, C. W. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha Cell 2002, 110, 763-773 10.1016/S0092-8674(02)00940-6
49. Chenna, R.; Sugawara, H.; Koike, T.; Lopez, R.; Gibson, T. J.; Higgins, D. G.; Thompson, J. D. Multiple sequence alignment with the Clustal series of programs Nucleic. Acids. Res. 2003, 31, 3497-3500 10.1093/nar/gkg500
50. Chang, D. K.; Li, P. C.; Lu, R. M.; Jane, W. N.; Wu, H. C. Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal models PLoS One 2013, 8, e83239 10.1371/journal.pone.0083239
51. Gao, X.; Cui, Y.; Levenson, R. M.; Chung, L. W.; Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots Nat. Biotechnol. 2004, 22, 969-976 10.1038/nbt994